Pathogenesis of non-alcoholic fatty liver disease

被引：547

作者：

Dowman, J. K. ^{[1
,3
]}

Tomlinson, J. W. ^{[2
]}

Newsome, P. N. ^{[1
,3
]}

机构：

[1] Univ Birmingham, Inst Biomed Res, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England

[2] Univ Birmingham, Ctr Endocrinol Diabet & Metab, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England

[3] Birmingham Queen Elizabeth Hosp, Liver Unit, Birmingham B15 2TH, W Midlands, England

来源：

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE | 2010年 / 103卷 / 02期

基金：

英国惠康基金;

关键词：

PLACEBO-CONTROLLED-TRIAL; NECROSIS-FACTOR-ALPHA; INCREASED INTESTINAL PERMEABILITY; SINGLE TOPIC CONFERENCE; NF-KAPPA-B; INSULIN-RESISTANCE; HEPATIC STEATOSIS; METABOLIC SYNDROME; UNITED-STATES; VITAMIN-E;

D O I：

10.1093/qjmed/hcp158

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：71 / 83

页数：13

共 134 条

[1]

Abdelmalek MF, 2001, AM J GASTROENTEROL, V96, P2711

[2] Nonalcoholic fatty liver disease [J].

Adams, LA ;

Angulo, P ;

Lindor, KD .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (07) :899-905

[3] A pilot trial of pentoxifylline in nonalcoholic steatohepatitis [J].

Adams, LA ;

Zein, CO ;

Angulo, P ;

Lindor, KD .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (12) :2365-2368

[4] Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis [J].

Aithal, Guruprasad P. ;

Thomas, James A. ;

Kaye, Philip V. ;

Lawson, Adam ;

Ryder, Stephen D. ;

Spendlove, Ian ;

Austin, Andrew S. ;

Freeman, Jan G. ;

Morgan, Linda ;

Weeber, Jonathan .

GASTROENTEROLOGY, 2008, 135 (04) :1176-1184

[5] Antifibrotic agents for liver disease [J].

Albanis, E ;

Friedman, SL .

AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (01) :12-19

[6] Effects of the 11β-hydroxysteroid dehydrogrenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes [J].

Andrews, RC ;

Rooyackers, O ;

Walker, BR .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) :285-291

[7] Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria [J].

Ayabe, T ;

Satchell, DP ;

Wilson, CL ;

Parks, WC ;

Selsted, ME ;

Ouellette, AJ .

NATURE IMMUNOLOGY, 2000, 1 (02) :113-118

[8]

Balkau B, 1999, DIABETIC MED, V16, P442

[9] Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study [J].

Bedogni, G ;

Miglioli, L ;

Masutti, F ;

Tiribelli, C ;

Marchesini, G ;

Bellentani, S .

HEPATOLOGY, 2005, 42 (01) :44-52

[10] A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis [J].

Belfort, Renata ;

Harrison, Stephen A. ;

Brown, Kenneth ;

Darland, Celia ;

Finch, Joan ;

Hardies, Jean ;

Balas, Bogdan ;

Gastaldelli, Amalia ;

Tio, Fermin ;

Pulcini, Joseph ;

Berria, Rachele ;

Ma, Jennie Z. ;

Dwivedi, Sunil ;

Havranek, Russell ;

Fincke, Chris ;

DeFronzo, Ralph ;

Bannayan, George A. ;

Schenker, Steven ;

Cusi, Kenneth .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2297-2307

← 1 2 3 4 5 6 7 8 9 10 →